UP!

CC $19.6   View long term graphs

The Chemours Company
Type
Public
Traded as NYSE: CC
S&P 400 Component
Industry Performance chemicals, titanium dioxide, Viton
Founded 2015 (2015)
Headquarters Wilmington, Delaware, United States
Area served
Global
Key people
Mark P. Vergnano (CEO), Richard H. Brown (Chairman)
Products
Revenue DecreaseUS$5.71 billion (2015)
Operating income
DecreaseUS$-132 million (2015)
Net income
DecreaseUS$-90 million (2015)
Total assets IncreaseUS$6.29 billion (2015)
Total equity DecreaseUS$126 million (2015)
Subsidiaries
Website Chemours.com

The Chemours Company, commonly referred to as Chemours, is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States.

In October 2013, DuPont announced that it was planning to spin off its "performance chemicals" business into a new publicly traded company in mid-2015. DuPont filed its initial Form 10 with the SEC in December 2014 and announced that the new company would be called "The Chemours Company". The spin-off to DuPont shareholders was completed on July 1, 2015 and Chemours' stock began trading on the New York Stock Exchange on the same date. Its 180,920,858 shares of common stock were distributed to DuPont shareholders at a par value of one cent each. Chemours has assumed various liabilities arising from lawsuits against DuPont.

Chemours manufactures and sells performance chemicals falling within three segments: Titanium Technologies (titanium dioxide); Fluoroproducts (refrigerants and industrial fluoropolymer resins and derivatives including Freon, Teflon and Viton); and Chemical Solutions (cyanide, sulfuric acid, aniline, methylamines, and reactive metals).


News

The Chemours Company -1.41% (basic materials)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2020 2020-11-02 Future report Set alerts
Q2 2020 2020-07-30 0.00 0.00
Q1 2020 2020-05-05 0.71 0.61
Q4 2019 2020-02-13 0.56 -1.94
Q3 2019 2019-11-04 0.59 0.46
Q2 2019 2019-08-01 0.72 0.57
Q1 2019 2019-05-02 0.63 0.55
Q4 2018 2019-02-14 1.05 0.81
Q3 2018 2018-11-01 1.49 1.51
Q2 2018 2018-08-02 1.71 1.53

Ratings

2016-06-15 Reiterated Rating Jefferies Group Hold
2016-05-13 Reiterated Rating Argus Hold
2016-05-09 Boost Price Target Barclays Overweight $14.00 to $15.00
2016-05-09 Boost Price Target Barclays PLC Overweight $14.00 to $15.00
2016-05-04 Reiterated Rating JPMorgan Chase & Co. Hold
2016-04-18 Boost Price Target Citigroup Inc. Neutral $5.00 to $8.00
2016-04-13 Reiterated Rating Jefferies Group Hold
2016-03-14 Upgrade Goldman Sachs Neutral to Buy $6.00 to $10.00
2016-03-14 Upgrade Goldman Sachs Group Inc. Neutral to Buy $6.00 to $10.00
2016-02-16 Downgrade Jefferies Buy to Hold $4.50
2016-02-16 Downgrade Jefferies Group Buy to Hold $4.50
2016-01-05 Lower Price Target Citigroup Inc. $7.00 to $6.00
2015-12-18 Reiterated Rating Barclays Overweight $19.00 to $14.00
2015-11-06 Lower Price Target Barclays Overweight $24.00 to $19.00
2015-09-28 Lower Price Target Jefferies Group Buy $24.00 to $17.00
2015-09-18 Initiated Coverage Argus Hold
2015-08-14 Initiated Coverage Citigroup Inc. Neutral $11.50
2015-08-07 Upgrade JPMorgan Chase & Co. Underweight to Neutral $16.00 to $11.00
2015-07-27 Initiated Coverage Susquehanna Neutral $13.00
2015-07-15 Initiated Coverage Goldman Sachs Neutral $15.00
2015-07-06 Initiated Coverage Barclays Overweight $24.00
2015-06-24 Initiated Coverage JPMorgan Chase & Co. Underweight $16.00
2015-06-22 Initiated Coverage Jefferies Group Buy $24.00
2016-06-15 Reiterated Rating Jefferies Group Hold
2016-05-13 Reiterated Rating Argus Hold
2016-05-09 Boost Price Target Barclays Overweight $14.00 to $15.00
2016-05-09 Boost Price Target Barclays PLC Overweight $14.00 to $15.00
2016-05-04 Reiterated Rating JPMorgan Chase & Co. Hold

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments